Elizabeth Balbin: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Undo revision 110521 by Notjusttired (talk)) |
Notjusttired (talk | contribs) m (Text replacement - "author-link8 = | last8" to "author-link7 = | last8") |
||
(152 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
[[File:Elizabeth Balbin.png|200px|thumb|right]] | [[File:Elizabeth Balbin.png|200px|thumb|right]] | ||
'''Elizabeth G. Balbin, MSc,''' is Clinical Research Director at the [[Institute for Neuro-Immune Medicine]] at [[Nova Southeastern University]] (NSU) in Florida.<ref>{{Cite web|url=https://www.nova.edu/nim/research/about-us.html|title=Our Team {{!}} Clinical Research {{!}} NSU Institute for Neuro Immune Medicine|last=NSU|first=|authorlink=|date=|website=NSU|publisher=Nova Southeastern University|language=en|archive-url=|archive-date=|url-status=|access-date=2019-01-11}}</ref> | '''Elizabeth G. Balbin, MA, MSc,''' is Clinical Research Director at the [[Institute for Neuro-Immune Medicine]] at [[Nova Southeastern University]] (NSU) in Florida.<ref>{{Cite web | url=https://www.nova.edu/nim/research/about-us.html | title = Our Team {{!}} Clinical Research {{!}} NSU Institute for Neuro Immune Medicine | last = NSU | first = | authorlink = | date = | website = NSU| publisher = Nova Southeastern University|language=en|archive-url=|archive-date=|url-status=|access-date=2019-01-11}}</ref> | ||
==Research studies== | ==Research studies== | ||
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015">{{Citation | *2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015">{{Citation | last = Klimas | first1 = N.G. | author-link1 = Nancy Klimas | last2 = Ironson | first2 = G. | authorlink2 = | last3 =Carter | first3 = A. | authorlink3 = | last4 = Balbin | first4 = E. | authorlink4 = Elizabeth Balbin | last5 = Bateman | first5 = L. | authorlink5 = Lucinda Bateman | last6 =Felsenstein | first6 =D. | author-link6 = Donna Felsenstein | last7 = Levine | first7 = S. | author-link8 = Susan Levine | last8 = Peterson | first8 =D. | author-link8 = Daniel Peterson | last9 =Chiu | first9 = K. | author-link9 = | last10 = Allen | first10 = A. | author-link10 = | last11 = Cunningham | first11 = K. | author-link11 = | last12 = Gottschalk | first12 = C.G. | author-link12 = Gunnar Gottschalk | last13 = Fletcher | first13 = M | author-link13 = Mary Ann Fletcher | last14 = Hornig | first14 = M. | author-link14 = Mady Hornig | last15 = Canning | first15 = C. | author-link15 = | last16 = Komaroff | first16 = A.L. | author-link16 = Anthony Komaroff | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | date = 2015 | pmid = | doi = 10.1080/21641846.2015.1023652 }}</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | ||
| | *2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015">{{Citation | last =Bateman | first1 = L. | author-link1 = Lucinda Bateman | last2 = Darakjy | first2 = S. | authorlink2 = | last3 = Klimas | first3 = N. | authorlink3 = Nancy Klimas | last4 = Peterson | first4 =D. | authorlink4 = Daniel Peterson | last5 = Levine | first5 = S.M. | authorlink5 = Susan Levine | last6 = Allen | first6 = A. | author-link6 = | last7 = Carlson | first7 = S.A. | author-link7 = | last8 = Balbin | first8 = E.G. | author-link8 = Elizabeth Balbin | last9 = Gottschalk | first9 = G. | author-link9 = Gunnar Gottschalk | last10 = March | first10 =D. | author-link10 = | title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | date = 2015 | pmid = | doi = 10.1080/21641846.2014.978109 }}</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | ||
| last2 | *2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline<ref name="IllnessProgressionBMC2016">{{Citation | last1 = Russell | first1 = Lindsey | author-link1 = | last2 = Broderick | first2 = Gordon | authorlink2 = Gordon Broderick | last3 = Taylor | first3 = Renee| authorlink3 = Renee Taylor | last4 = Fernandes | first4 = Henrique | authorlink4 = | last5 = Harvey | first5 = Jeanna | authorlink5 = Jeanna Harvey | last6 = Barnes | first6 = Zachary | author-link6 = Zachary Barnes | last7 = Smylie | first7 = AnneLiese | author-link7 = | last8 = Collado | first8 = Fanny| author-link8 = | last9 = Balbin | first9 = Elizabeth | author-link9 = Elizabeth Balbin | last10 = Katz | first10 = Ben | author-link10 = Ben Katz | last11 = Klimas | first11 = Nancy | author-link11 = Nancy Klimas | last12 = Fletcher | first12 = Mary Ann | author-link12 = Mary Ann Fletcher | title = Illness progression in chronic fatigue syndrome: a shifting immune baseline | journal = BMC Immunology | ||
| last3 | | year = 2016 | pmid = | doi = 10.1186/s12865-016-0142-3 }}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785654/ (Full Text)] | ||
| last4 | *2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017">{{Citation | last =Unger | first1 = Elizabeth R. | author-link1 = Elizabeth Unger | last2 = Lin | first2 = Jin-Mann S. | authorlink2 = Jin-Mann Sally Lin | last3 =Tian | first3 = Hao | authorlink3 = | last4 = Natelson | first4 = Benjamin H | authorlink4 = Benjamin Natelson | last5 = Lange | first5 = Gudrun | authorlink5 = Gudrun Lange | last6 = Vu | first6 = Diana | author-link6 = | last7 = Blate | first7 = Michelle | author-link7 = | last8 = Klimas | first8 = Nancy G. | author-link8 = Nancy Klimas | last9 =Balbin | first9 = Elizabeth G. | author-link9 = Elizabeth Balbin | last10 = Bateman | first10 = Lucinda | author-link10 = Lucinda Bateman | last11 = Allen | first11 = Ali | author-link11 = | last12 = Lapp | first12 = Charles W. | author-link12 = Charles Lapp | last13 = Springs | first13 = Wendy | author-link13 = | last14 = Kogelnik | first14 = Andreas M. | author-link14 = Andreas Kogelnik | last15 = Phan | first15 = Catrina C. | author-link15 = | last16 = Danver | first16 = Joan | author-link16 = | last17 = Podell | first17 = Richard N. | author-link17 = Richard Podell | last18 = Fitzpatrick | first18 = Trisha | author-link18 = | last19 = Peterson | first19 = Daniel L. | author-link19 = Daniel Peterson | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | last22 = MCAM Study Group | title = Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. | journal = American Journal of Epidemiology | volume = 1-10 | issue = | page = | date = 2017 | pmid = | doi = 10.1093/aje/kwx029 }}</ref> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | ||
| last5 | *2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome<ref>{{Cite journal | last = Morris | first = Matthew C. | author-link = Matthew Morris | last10 = Fletcher | first10 = Mary Ann | author-link10 = Mary Ann Fletcher | last2 = Cooney | first2 = Katherine E. | authorlink2 = | last3 = Sedghamiz | first3 = Hooman | authorlink3 = | last4 = Abreu | first4 = Maria | authorlink4 = | last5 = Collado | first5 = Fanny | authorlink5 = | last6 = Balbin | first6 = Elizabeth G. | author-link6 = Elizabeth Balbin | last7 = Craddock | first7 = Travis J.A. | author-link8 = Travis Craddock | last8 = Klimas | first8 = Nancy G. | author-link8 = Nancy Klimas | last9 = Broderick | first9 = Gordon | author-link9 = Gordon Broderick | date = Mar 2019 | title = Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome | url =https://linkinghub.elsevier.com/retrieve/pii/S0149291819301122|journal=Clinical Therapeutics|language=en|volume=|issue= | pages = |doi=10.1016/j.clinthera.2019.03.002|quote=|via=}}</ref> [https://www.sciencedirect.com/science/article/abs/pii/S0149291819301122?via%3Dihub (Abstract)] | ||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | |||
*2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | |||
*2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline<ref name="IllnessProgressionBMC2016">{{Citation | |||
| last1 | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 = Barnes | |||
| last7 = Smylie | |||
| last8 = Collado | |||
| last9 = Balbin | |||
| last10 = Katz | |||
| last11 = Klimas | |||
| last12 = Fletcher | |||
| title | |||
| journal = BMC Immunology | |||
| year = 2016 | |||
| pmid = | |||
| doi = 10.1186/s12865-016-0142-3 | |||
}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785654/ (Full Text)] | |||
*2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| last18 | |||
| last19 | |||
| last20 | |||
| last21 | |||
| last22 | |||
| title | |||
| journal = American Journal of Epidemiology | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | |||
*2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome<ref>{{Cite journal|last=Morris|first=Matthew C.|author-link=Matthew Morris|last10=Fletcher|first10=Mary Ann|author-link10=Mary Ann Fletcher|last2=Cooney|first2=Katherine E.| | |||
== Online presence == | == Online presence == |
Latest revision as of 20:02, July 29, 2023
Elizabeth G. Balbin, MA, MSc, is Clinical Research Director at the Institute for Neuro-Immune Medicine at Nova Southeastern University (NSU) in Florida.[1]
Research studies[edit | edit source]
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[2] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[3] (Abstract)
- 2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline[4] (Full Text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[5] (Full Text)
- 2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome[6] (Abstract)
Online presence[edit | edit source]
References[edit | edit source]
- ↑ NSU. "Our Team | Clinical Research | NSU Institute for Neuro Immune Medicine". NSU. Nova Southeastern University. Retrieved January 11, 2019.
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Russell, Lindsey; Broderick, Gordon; Taylor, Renee; Fernandes, Henrique; Harvey, Jeanna; Barnes, Zachary; Smylie, AnneLiese; Collado, Fanny; Balbin, Elizabeth; Katz, Ben; Klimas, Nancy; Fletcher, Mary Ann (2016), "Illness progression in chronic fatigue syndrome: a shifting immune baseline", BMC Immunology, doi:10.1186/s12865-016-0142-3
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Morris, Matthew C.; Cooney, Katherine E.; Sedghamiz, Hooman; Abreu, Maria; Collado, Fanny; Balbin, Elizabeth G.; Craddock, Travis J.A.; Klimas, Nancy G.; Broderick, Gordon; Fletcher, Mary Ann (March 2019). "Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.03.002.
This article is a stub. |